News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche Molecular Systems, Inc. (RHHBF.PK) Release: Blood Screening Test That Offers Immediate Viral Discrimination for Three Major Viruses Receives CE Mark



12/9/2011 4:48:28 PM

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the cobas® TaqScreen MPX Test, version 2.0 for use on the cobas s 201 system is now commercially available in Europe.

This latest version of the widely used cobas® TaqScreen MPX Test provides increased sensitivity and is the only commercially available test that provides simultaneous viral target resolution on an automated system, removing the need for further time-consuming testing of positive units.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES